Medtronic has had a lot of action in the courts today, with the Supreme Court sending a negligence lawsuit against the company up to the federal government for a 2nd opinion. The Justices asked the White House to weigh in on a lawsuit that questions preemption laws for medical devices...
C.R. Bard tied a bow on its previously announced acquisition of Minnesota-based Medafor in a deal worth up to $280 million. Officially consummated on October 1, the deal provided $200 million up-front and another possible $80 million for Medafor and its line of anti-bleeding agents.
Medical technology giant GE Healthcare won European regulatory approval for the latest in its line of Vivid E9 ultrasound systems with XDclear technology. The next-generation system with XDclear features enhanced image quality in 2D, 4D, color and Doppler, tools that can help with hard-to-image patients, including those who are obese.
A C.R. Bard subsidiary settled a lawsuit filed against it by VasoNova alleging that Bard and an ex-technology chief stole trade secrets to set up a new company. VasoNova makes a system that uses Doppler ultrasound and intravascular ECG to help cardiologists place catheters in the heart.
Royal Philips and Accenture today announced the creation of a proof-of-concept demonstration that uses a Google Glass head-mounted display for researching ways to improve the effectiveness and efficiency of performing surgical procedures. The demonstration connects Google Glass to Philips IntelliVue Solutions...
Royal Philips and Accenture today announced the creation of a proof-of-concept demonstration that uses a Google Glass™ head-mounted display for researching ways to improve the effectiveness and efficiency of performing surgical procedures. The demonstration connects Google Glass to Philips IntelliVue Solutions...
Medtronic Diabetes tells Evidenced-Based Diabetes Management that it has applied to CMS for a new code that would cover sensor-augmented insulin pumps, which would broaden Medicare coverage for the new “artificial pancreas” system it unveiled on Friday.
Drug delivery coatings are not a new technology to the medical device industry. However, as more implantable devices are tasked with achieving a greater level of healthcare, they do offer great benefit to design engineers. This article reviews drug coating technology and looks at application areas where it has made a significant impact.
Healthcare giant Baxter announced that it fired nearly 100 employees from a Medina, N.Y., amid an FDA inquiry into the Sigma Spectrum infusion pump manufactured there. The FDA has asked Baxter to provide additional information into modifications proposed for the medical device, forcing Baxter to suspend shipments since April of this year.
The U.S. Defense Dept. issued $83.9 million worth of contracts to 4 medical device companies, according to the agency's daily press release. Cardinal Health was the biggest recipient, with the government exercising a 4th-year contract option with the Illinois-based company, for more than $40 million. The contract is for "various medical and surgical products."
Medtronic Gains Approval of First Artificial Pancreas Device System with Threshold Suspend AutomationSeptember 27, 2013 10:19 am | by Medtronic | News | Comments
Medtronic, Inc. has announced the FDA approval of the MiniMed 530G with Enlite, a breakthrough, first-generation artificial pancreas system with Threshold Suspend automation for people with diabetes. Medtronic’s system is the first in the United States that can automatically stop insulin delivery when sensor glucose values reach a preset level...
GE Healthcare Announces Agreement with Research Group at Karolinska Institutet, Sweden to Provide Next Generation Sequencing ServicesSeptember 27, 2013 4:00 am | by Business Wire | News | Comments
GE Healthcare (GEHC), a unit of GE (NYSE: GE) announced today that it has won a tender to exclusively provide next generation sequencing services to a research group at Karolinska Institutet in Sweden. The sequencing services will be provided by a subsidiary of GE Healthcare, SeqWright Genomic Services, a Houston, Texas-based provider of nucleic acid sequencing and other genomic services.
Federal agencies have handed out a slew of contracts and contract extensions in recent weeks, including about $370 million in deals for medical supplies and devices. The biggest takers were Becton Dickinson & Co., Johnson & Johnson, and Synthes, who together claimed more than half of the contract funding.
A California state court ruled out a series of motions seeking to dismiss a lawsuit filed over bone proteins made by Stryker and Medtronic, ruling that federal law does not preempt the case from going forward. April Cabana sued the medical device companies for alleged off-label promotion of the bone growth products...
Shares of medical device makers rose Wednesday after Stryker Corp. agreed to buy robotic surgery system maker Mako Surgical for $1.41 billion. Stryker will pay $30 per share for Mako, an 86 percent premium based on the stock's latest closing price.
Stryker will spend $1.41 billion to acquire Mako Surgical and all of its robotic assisted surgery technology. The medical device maker will pay $30 per Mako share, an 86 percent premium to its $16.17 closing price Tuesday. The companies put the deal's value at about $1.65 billion.
California medical device maker Ivera Medical announced a 2nd lawsuit against Covidien, this time in a district court in Southern California, claiming infringement of patents for disinfecting caps for medical devices. The new lawsuit alleged infringement of a 4th patent...
FDA Approves Medtronic's Complete 'SE' Vascular Stent for Use in Superficial Femoral and Proximal Popliteal (Leg) ArteriesSeptember 24, 2013 11:42 am | by The Associated Press | News | Comments
Expanding its role in the treatment of peripheral artery disease in the United States, Medtronic, Inc. (NYSE: MDT) announced today that the U.S. Food and Drug Administration (FDA) has approved the Complete SE (self-expanding) vascular stent for use in the lower extremities -- specifically, the superficial femoral artery (SFA) and proximal popliteal artery (PPA), which carry blood through the upper legs.
Minnesota medical device company Medtronic is closing the books on a years-old wage discrimination case, paying $290,000 to settle claims that it paid Hispanic workers less than white workers. Filed by the U.S. Dept. of Labor, the lawsuit claimed that Medtronic shortchanged 78 Hispanic entry-level employees at a Danvers, Mass., facility.
B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, announced today that it has received FDA approval of 0.9% Sodium Chloride for Irrigation in 2L and 3L containers. The approval initiates B.Braun's launch of TITAN® XL, a line of flexible bags that offers large-volume irrigation and parenteral nutrition solutions for compounding.
Medtronic, Inc. has announced clinical trial results showing that heart failure patients treated with its exclusive AdaptivCRT feature experienced a nearly 50 percent reduction in atrial fibrillation (AF) risk. Pioneered by Medtronic, the AdaptivCRT technology is a feature on certain cardiac resynchronization therapy-defibrillators...
Abbott announced today it has received CE Marking in Europe for the FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System™. The new icon-driven system provides sleek design, visual glucose trend indicators and insulin logging – all delivered in a single device to support daily diabetes management.
Covidien said its board of directors authorized a restructuring plan aimed at saving up to $300 million a year by fiscal 2018, with manufacturing and distribution operations slated to be closed. Covidien did not reveal how many layoffs would be involved.
Medical device maker Boston Scientific (NYSE:BSX) issued new warnings on its Cognis and Teligen implantable cardioverter defibrillators, advising physicians to watch out for premature battery depletion in older models. The problematic implants are no longer available and haven't been manufactured since December 2009...
Wendy Fleishman of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announced that two new videos have been posted on YouTube addressing common concerns and questions asked by hip replacement patients who received notice of the recall of their Stryker Rejuvenate or Stryker ABG II hip implant.